Association of Low Leptin with Poor 3-Month Prognosis in Ischemic Stroke Patients with Type 2 Diabetes

References

• Auwerx J, Staels B. Leptin. Lancet. 1998;351(9104):737–742. doi:10.1016/S0140-6736(97)06348-49504534
   PubMed Web of Science ®Google Scholar
• Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62(1):413–437. doi:10.1146/annurev.physiol.62.1.41310845097
   PubMed Web of Science ®Google Scholar
• Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12(1):57–65. doi:10.1096/fsb2fasebj.12.1.579438411
   PubMed Web of Science ®Google Scholar
• McNeely MJ, Boyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care. 1999;22(1):65–70.10333905
   PubMed Web of Science ®Google Scholar
• Ghadge AA, Khaire AA. Leptin as a predictive marker for metabolic syndrome. Cytokine. 2019;121:154735.31154250
   PubMed Web of Science ®Google Scholar
• Ghantous CM, Azrak Z, Hanache S, Abou-Kheir W, Zeidan A. Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol. 2015;2015:1–13. doi:10.1155/2015/534320
   Web of Science ®Google Scholar
• Beltowski J. Leptin and atherosclerosis. Atherosclerosis. 2006;189(1):47–60. doi:10.1016/j.atherosclerosis.2006.03.00316580676
   PubMed Web of Science ®Google Scholar
• Knudson JD, Dincer UD, Zhang C, et al. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2005;289(1):H48–H56.15749744
   PubMed Web of Science ®Google Scholar
• Coppari R, Bjørbæk C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov. 2012;11(9):692–708.22935803
   PubMed Web of Science ®Google Scholar
• Reilly MP, Iqbal N, Schutta M, et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(8):3872–3878. doi:10.1210/jc.2003-03167615292320
   PubMed Web of Science ®Google Scholar
• Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018;39(7):1176–1188.29877321
   PubMed Web of Science ®Google Scholar
• Söderberg S, Stegmayr B, Stenlund H, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med. 2004;256(2):128–136. doi:10.1111/j.1365-2796.2004.01351.x15257725
   PubMed Web of Science ®Google Scholar
• Yang H, Guo W, Li J, et al. Leptin concentration and risk of coronary heart disease and stroke: a systematic review and meta-analysis. PLoS One. 2017;12(3):e0166360. doi:10.1371/journal.pone.016636028278178
   PubMed Web of Science ®Google Scholar
• Bidulescu A, Liu J, Chen Z, et al. Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in African Americans: the Jackson heart study. Front Public Health. 2013;1:16. doi:10.3389/fpubh.2013.0001624350185
   PubMed Web of Science ®Google Scholar
• Liu G, Dong M, Ma S, et al. Serum leptin is associated with first-ever ischemic stroke, lesion size and stroke severity in a Chinese cohort. Neurol Res. 2019;41(2):125–131. doi:10.1080/01616412.2018.154439930433860
   PubMed Web of Science ®Google Scholar
• Jimenez I, Sobrino T, Rodriguez-Yanez M, et al. High serum levels of leptin are associated with post-stroke depression. Psychol Med. 2009;39(7):1201. doi:10.1017/S003329170900563719356259
   PubMed Web of Science ®Google Scholar
• Gairolla J, Kler R, Modi M, Khurana D. Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke. Rev Neurosci. 2017;28(3):295–306.28121618
   PubMed Web of Science ®Google Scholar
• Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541–553.1088404
   PubMed Web of Science ®Google Scholar
• Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–1101. doi:10.1056/NEJMoa090829220335585
   PubMed Web of Science ®Google Scholar
• Sims JR, Gharai LR, Schaefer PW, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009;72(24):2104–2110. doi:10.1212/WNL.0b013e3181aa532919528517
   PubMed Web of Science ®Google Scholar
• Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.357678184
   PubMed Web of Science ®Google Scholar
• Huang GQ, Cheng HR, Wu YM, et al. Reduced vitamin D levels are associated with stroke-associated pneumonia in patients with acute ischemic stroke. Clin Interv Aging. 2019;14:2305–2314. doi:10.2147/CIA.S23025532021127
   PubMed Web of Science ®Google Scholar
• Tu WJ, Dong X, Zhao SJ, Yang DG, Chen H. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol. 2013;25(9):771–778. doi:10.1111/jne.1205223701638
   PubMed Web of Science ®Google Scholar
• Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64(1):24–34.25199978
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang S, Signore AP, Chen J. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke. 2007;38(8):2329–2336. doi:10.1161/STROKEAHA.107.48278617600230
   PubMed Web of Science ®Google Scholar
• Valerio A, Dossena M, Bertolotti P, et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-κB/c-Rel–dependent transcription. Stroke. 2009;40(2):610–617. doi:10.1161/STROKEAHA.108.52858819023096
   PubMed Web of Science ®Google Scholar
• Zhang JY, Yan GT, Liao J, et al. Leptin attenuates cerebral ischemia/reperfusion injury partially by CGRP expression. Eur J Pharmacol. 2011;671(1–3):61–69. doi:10.1016/j.ejphar.2011.09.17021968137
   PubMed Web of Science ®Google Scholar
• Zhang J, Deng Z, Liao J, et al. Leptin attenuates cerebral ischemia injury through the promotion of energy metabolism via the PI3K/Akt pathway. J Cereb Blood Flow Metab. 2013;33(4):567–574. doi:10.1038/jcbfm.2012.20223299243
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen J. Leptin protects hippocampal CA1 neurons against ischemic injury. J Neurochem. 2008;107(2):578–587. doi:10.1111/j.1471-4159.2008.05645.x18752642
   PubMed Web of Science ®Google Scholar
• Avraham Y, Davidi N, Porat M, et al. Leptin reduces infarct size in association with enhanced expression of CB2, TRPV1, SIRT-1 and leptin receptor. Curr Neurovasc Res. 2010;7(2):136–143. doi:10.2174/15672021079118494320374198
   PubMed Web of Science ®Google Scholar
• Avraham Y, Dayan M, Lassri V, et al. Delayed leptin administration after stroke induces neurogenesis and angiogenesis. J Neurosci Res. 2013;91(2):187–195. doi:10.1002/jnr.2314723152300
   PubMed Web of Science ®Google Scholar
• Meek TH, Morton GJ. The role of leptin in diabetes: metabolic effects. Diabetologia. 2016;59(5):928–932.26969486
   PubMed Web of Science ®Google Scholar
• Desilles JP, Meseguer E, Labreuche J, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke. 2013;44(7):1915–1923. doi:10.1161/STROKEAHA.111.00081323704108
   PubMed Web of Science ®Google Scholar
• Frühbeck G, Catalán V, Rodríguez A, et al. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017;7(1):1–8. doi:10.1038/s41598-017-06997-028127051
   PubMed Web of Science ®Google Scholar
• Signore AP, Zhang F, Weng Z, Gao Y, Chen J. Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J Neurochem. 2008;106(5):1977–1990. doi:10.1111/j.1471-4159.2008.05457.x18466320
   PubMed Web of Science ®Google Scholar
• Calleja AI, Cortijo E, García-Bermejo P, et al. Blood biomarkers of insulin resistance in acute stroke patients treated with intravenous thrombolysis: temporal profile and prognostic value. Diabetes Res Clin Metab. 2013;2(1):2. doi:10.7243/2050-0866-2-2
   Google Scholar
• Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B, Whooley MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the heart and soul study. Atherosclerosis. 2011;217(2):503–508. doi:10.1016/j.atherosclerosis.2010.10.04721176905
   PubMed Web of Science ®Google Scholar
• Carbone F, Burger F, Roversi G, et al. Leptin/adiponectin ratio predicts poststroke neurological outcome. Eur J Clin Invest. 2015;45(11):1184–1191. doi:10.1111/eci.1253826381386
   PubMed Web of Science ®Google Scholar
• Wolk R, Bertolet M, Singh P, et al. Prognostic value of adipokines in predicting cardiovascular outcome: explaining the obesity paradox. Mayo Clin Proc. 2016;91(7):858–866. doi:10.1016/j.mayocp.2016.03.02027289411
   PubMed Web of Science ®Google Scholar
• Puurunen VP, Kiviniemi A, Lepojärvi S, et al. Leptin predicts short-term major adverse cardiac events in patients with coronary artery disease. Ann Med. 2017;49(5):448–454. doi:10.1080/07853890.2017.130167828300429
   PubMed Web of Science ®Google Scholar
• Söderberg S, Colquhoun D, Keech A, et al. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes. 2009;33(1):123–130. doi:10.1038/ijo.2008.224
   Web of Science ®Google Scholar
• Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004;44(9):1819–1824. doi:10.1016/j.jacc.2004.07.05015519013
   PubMed Web of Science ®Google Scholar
• Wallander M, Söderberg S, Norhammar A. Leptin – a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known type 2 diabetes. Diabet Med. 2008;25(8):949–955. doi:10.1111/j.1464-5491.2008.02509.x18959608
   PubMed Web of Science ®Google Scholar
• Brennan AM, Li TY, Kelesidis I, Gavrila A, Hu FB, Mantzoros CS. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia. 2007;50(6):1178–1185. doi:10.1007/s00125-007-0635-y17372717
   PubMed Web of Science ®Google Scholar